Contracts Finder notice
NHS Framework - Blood Disorders including Haemophilia A and B - July 2024
Authority: NHS England
What is being bought
Published requirement descriptionProject Title: NHS National Framework Agreement for the supply of products for the treatment of Blood Disorders including Haemophilia A and B - July 2024
Offer reference number: CM/PHS/22/5661
Period of framework: 1 July 2024 to 30 April 2027 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 14 months.
Published By: Medicines Procurement and Supply Chain - NHS Medicines Value & Access, NHS England
Published procurement details
- Procedure
- Open procedure (above threshold)
- Buyer reference
- CF-2393800D0O000000rwimUAA
- Category
- Goods
- Tender status
- Complete
- Award status
- Active
- Suitable for SMEs
- Yes
- Suitable for voluntary, community and social enterprises
- No
- Tender deadline
- Procurement method
- Open
- Item 1: Delivery locations as published
WA7 2ES; East Midlands, United Kingdom; East of England, United Kingdom; London, United Kingdom; North East, United Kingdom; North West, United Kingdom; Scotland, United Kingdom; South East, United Kingdom; South West, United Kingdom; Wales, United Kingdom; West Midlands, United Kingdom; Yorkshire and the Humber, United Kingdom; Northern Ireland, United Kingdom
Key dates
Published dates- Award decision31 May 2024
- Notice published11 Jun 2024
- Contract starts1 Jul 2024
- Contract ends30 Apr 2027
Contracting authority & participating public bodies
- NHS EnglandContracting authority
Suppliers named on the notice
- Pfizer LtdSupplier
- Business size
- Large
- Roche Products LtdSupplier
- Business size
- Large
- Novo NordiskSupplier
- Business size
- Large
- Sobi (Swedish Orphan Biovitrum Ltd)Supplier
- Business size
- SME
- Takeda UK LtdSupplier
- Business size
- Large
- LFBSupplier
- Business size
- Large
- Bio Products Laboratory LtdSupplier
- Business size
- Large
- Octapharma LimitedSupplier
- Business size
- Large
- CSL Behring UK LtdSupplier
- Business size
- Large
Official documents & specifications (7)
Official links; attachments are not copiedTender pack and attachments
- 03 Framework Agreement and Terms and Conditions - CM-PHS-22-5661
- 2024 S 000-016397 - F14_ Corrigendum Notice for changes or additional information
- FTS - 005350-2024 - OPPORTUNITY NOTICE Blood Disorders including Haemophilia A and B - July 2024
- Document No. 09 - Participating Authorities CM-PHS-22-5661
- Transparency Award Schedules - CM-PHS-22-5661
- Parties appointed to the framework agreement - CM-PHS-22-5661
Notices published for this procedure
Source record
- Source
- Contracts Finder
- Notice language
- en
- Release reference
- ocds-b5fd17-78480ca7-506a-4fbd-ab2d-b535c8904519-2024-07-24T15:44:07+01:00
- Published
- 11 Jun 2024
- Latest update
- 24 Jul 2024
- Procedure reference
- ocds-b5fd17-78480ca7-506a-4fbd-ab2d-b535c8904519
- Contract reference
- ocds-b5fd17-78480ca7-506a-4fbd-ab2d-b535c8904519-2